![](/img/cover-not-exists.png)
750PPhase Ib study of PF-04136309 (an oral CCR2 inhibitor) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic adenocarcinoma
Noel, M., Lowery, M., Ryan, D., Wolpin, B., Bullock, A., Britten, C., Jin, B., Ganguly, B.J., Taylor, C.T., Yin, D., Wunderlich, D.A., Gamelin, E.C., Linehan, D.C.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.132
Date:
September, 2017
File:
PDF, 52 KB
english, 2017